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Introduction
Little information is available on prevalence of extended-
spectrum-betalactamase-producing Enterobacteriaceae
(ESBL-E) with and without additional resistance to fluoro-
quinolones. In Germany, Enterobacteriaceae are classified
according to their susceptibility to four classes of antimi-
crobial substances. Only organisms resistant to acylureido-
penicillins, 3rd and 4th generation cephalosporins and
fluoroquinolones are labelled as “multidrug–resistant”.
Objectives
The aim of this prospective analysis was to gain evidence
on admission prevalence and incidence of ESBL-E with
and without resistance to fluorochinolones in non-ICUs
in a German university hospital.
Methods
This analysis is part of the R-GNOSIS framework. WP
5 investigates the benefits of isolation precautions over
standard measures for ESBL-E-carriers in non-ICUs.
Rectal swabs are obtained for all patients admitted to
the participating wards within 3 days of admission.
Patients staying longer than 3 days are screened every
7 days thereafter and before discharge. Chromogenic
culture media are used for ESBL-screening, identifica-
tion and susceptibility testing is performed using Vitek
2 (bioMérieux, Germany).
Results
Between February 2014 and February 2015, 8317 patients
were admitted to 8 medical and surgical wards. An admis-
sion sample was obtained for 6047 patients (73%). Among
all 8317 patients, 6814 patients had a LOS of more than 3
days, and 4083 patients were screened at least twice (60%).
The majority of ESBL-E-carriers was identified on
admission (n=607, 10.1%). However, 197 patients (4.8%)
were screened negative on admission and turned ESBL-
positive during their stay. Admission prevalence of
ESBL-E resistant to fluorochinolones was 4.7% (n=286),
and 2.7% (n=111) of patients turned positive during
their stay.
Conclusion
More than 50% of ESBL-E were susceptible to fluorochi-
nolones. As the increase of ESBL-E is a worldwide concern
and resources to prevent their spread are limited, focusing
on ESBL-E according to their antimicrobial susceptibility
pattern may be a pragmatic approach.
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